We are live on ! Find out more
GCM

Galibier Capital Management Portfolio holdings

AUM $300M
1-Year Est. Return 22.03%
This Fund
S&P 500
This Quarter Est. Return
+5.19%
1 Year Est. Return
+22.03%
3 Year Est. Return
+66.83%
5 Year Est. Return
+107.72%
10 Year Est. Return
AUM
$315M
AUM Growth
+$63.6M
Cap. Flow
+$44M
Cap. Flow %
13.96%
Top 10 Hldgs %
79.65%
Holding
36
New
5
Increased
7
Reduced
20
Closed
1

Top Buys

Rank Stock Value
1
RCI icon
Rogers Communications
RCI
+$31.6M
2
AZN icon
AstraZeneca
AZN
+$14.2M
3
GIL icon
Gildan
GIL
+$13.4M
4
PHG icon
Philips
PHG
+$7.26M
5
CVE icon
Cenovus Energy
CVE
+$5.57M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$14.5M
2
OSK icon
Oshkosh
OSK
+$4.75M
3
SRCL
Stericycle Inc
SRCL
+$4M
4
EMR icon
Emerson Electric
EMR
+$3.53M
5
RYAAY icon
Ryanair
RYAAY
+$2.29M

Sector Composition

Rank Sector Weight
1 Financials 29.21%
2 Energy 16.31%
3 Healthcare 13.72%
4 Communication Services 10.75%
5 Materials 10.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RYAAY icon
26
Ryanair
RYAAY
$31.8B
$1.18M 0.38%
33,785
-71,483
-68% -$2.29M
CTSH icon
27
Cognizant
CTSH
$25.1B
$1.06M 0.34%
17,025
-15,194
-47% -$939K
TFC icon
28
Truist Financial
TFC
$64.6B
$968K 0.31%
17,195
-18,398
-52% -$996K
CL icon
29
Colgate-Palmolive
CL
$74.4B
$927K 0.29%
13,469
-9,439
-41% -$644K
TMO icon
30
Thermo Fisher Scientific
TMO
$214B
$840K 0.27%
2,585
GOOG icon
31
Alphabet (Google) Class C
GOOG
$4.4T
$767K 0.24%
11,480
-21,040
-65% -$1.36M
MDT icon
32
Medtronic
MDT
$110B
$748K 0.24%
6,590
-4,560
-41% -$500K
GOOGL icon
33
Alphabet (Google) Class A
GOOGL
$4.43T
$513K 0.16%
7,660
BSV icon
34
Vanguard Short-Term Bond ETF
BSV
$44.6B
$183K 0.06%
+2,267
New +$183K
BND icon
35
Vanguard Total Bond Market
BND
$158B
$182K 0.06%
+2,176
New +$183K
SRCL
36
DELISTED
Stericycle Inc
SRCL
-78,596
Closed -$4M

Similar funds

Galibier Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Galibier Capital Management held 36 positions worth $315M, up 25% from $251M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Galibier Capital Management deployed $44M of net new capital in Q4 2019, opening 5 new positions and adding to 7 existing holdings. Its largest new stake was Rogers Communications: 655,221 shares worth $32.6M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, down from 33% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was AbbVie, an estimated $14.5M trimmed.

  • Galibier Capital Management's largest Q4 2019 buy was Rogers Communications: 655,221 shares worth $32.6M.
  • Galibier Capital Management added most to AstraZeneca in Q4 2019, an estimated $14.2M increase.
  • Galibier Capital Management's biggest Q4 2019 reduction was AbbVie, cutting an estimated $14.5M.
  • Galibier Capital Management fully exited Stericycle Inc in Q4 2019, selling an estimated $4M.
  • Galibier Capital Management's ten largest holdings make up 80% of its $315M portfolio in Q4 2019.
  • Galibier Capital Management opened 5 new positions and closed 1 in Q4 2019.
  • Galibier Capital Management's portfolio value rose 25% quarter-over-quarter to $315M.

Based on Galibier Capital Management's 13F filing for Q4 2019, filed 14 Jan 2020.